Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Syngenta To Acquire Pasteuria Bioscience
by Melody M. Bomgardner
September 24, 2012
| A version of this story appeared in
Volume 90, Issue 39
Swiss crop protection firm Syngenta has agreed to buy U.S.-based Pasteuria Bioscience for $86 million plus deferred payments of up to $27 million. Pasteuria produces biological products, derived from soil bacteria of the genus Pasteuria, to control plant-parasitic nematodes. The company’s first product, a seed treatment to control the soybean cyst nematode, is set to launch in the U.S. in 2014. The deal follows Bayer CropScience’s recent acquisition of biological pesticide maker AgraQuest and Monsanto’s alliance with Alnylam to develop biopesticides based on RNAi technology.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter